Increasing Medical Student Confidence When Treating LGBTQIA+ Patients With Cherry Au, MD
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Increasing Medical Student Confidence When Treating LGBTQIA+ Patients Following the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Cherry Au, MD, of Rush University Medical Center, spoke with Oncology Data Advisor to discuss her abstract, Medical Student Clinical Cultural Awarene...
Understanding the Research on Novel Treatments and Nutritional Interventions for Multiple Myeloma With Urvi Shah, MD
Keira Smith
Expert Analysis
During the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Urvi Shah from Memorial Sloan Kettering Cancer Center sat down with Oncology Data Advisor to share her perspectives on the exciting research that was presented in the poster discussion session she chaired on novel therapies for multiple myeloma. In addition, Dr. Shah explains more about her work to impact patients' quality of life and outcomes through nutritional interventions.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Please Move: Get Your Oncology Patients Exercising With Karen Basen-Engquist, PhD, MPH
Lyn Brook
Expert Analysis
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Karen Basen-Engquist, PhD, MPH, Director of the Center for Energy Balance in Cancer Prevention and Survivorship at The University of Texas MD Anderson Cancer Center, sat down with Oncology Data Advisor after presenting her education session on behavioral strategies to get your patients with cancer exercising and why it is important.  
Tackling Violence and Stigmatization to Decrease Cancer Disparities for Transgender Patients With Ash Alpert, MD, MFA
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Tackling Violence and Stigmatization to Decrease Disparities for Transgender Patients: Ash Alpert At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Dr. Ash Alpert, a postdoctoral fellow in health services research at Brown University, presented two posters regarding the associations between violence and cancer risk factors for transgender and cisgender people. In this follow-up interview with Oncology Data Advisor, Dr. Alpert delves further into the implications of these two studies' results and shares how their ongoing research in this field seeks to improve the care of transgender people in the health care setting.  
Epic Experiences Available for Cancer Survivors With Colin Ferro
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Thriving Beyond the Cancer Diagnosis: Colin Ferro At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Colin Ferro, Director of Operations at Epic Experience, spoke with Oncology Data Advisor about the organization's mission to empower adult cancer survivors and thrivers beyond their diagnosis and treatment. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Understanding Antibody-Drug Conjugates and Their Use in the Treatment of Breast Cancer With Ian Krop, MD, PhD
Elizabeth Heller, PhD
Expert Analysis
Oncology Data Advisor™ · Patritumab Deruxtecan for HER3-Expressing Metastatic Breast Cancer: Ian Krop, MD, PhD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Ian Krop, Director of the Yale Cancer Center Clinical Trials Office, sat down with Oncology Data Advisor to discuss his research and the data he presented regarding the HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) for treatment of metastatic breast cancer.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMED.  
Guiding Colorectal Cancer Treatment Decisions by Using ctDNA With Jeanne Tie, MD, MBChB, FRACP
Elizabeth Heller, PhD
Expert Analysis
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Jeanne Tie spoke with Oncology Data Advisor to share more about her presentation regarding the clinical utility of circulating tumor DNA (ctDNA) analysis to guide treatment decision making for patients with colorectal cancer.  
Bridging Disparities in Breast Cancer Morbidity and Mortality in Women of Color With Jessica Jones, MD
Eden Maack
Expert Analysis
Oncology Data Advisor™ · Breast Cancer Prevention and Disparities: Jessica Jones, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Jessica Jones, Assistant Professor of Oncology at the University of Texas (UT) Health System, sat down with Oncology Data Advisor to discuss her work in cancer detection and cancer prevention in Black women with a higher risk of developing breast cancer and bridging the racial gap in breast cancer morbidity and mortality with early detection and prevention.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.
Advancing Treatment for Non–Small Cell Lung Cancer: Exploring the Results of Adagrasib With Alexander Spira, MD, PhD, FACP
Lyn Brook
Expert Analysis
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Alexander Spira, MD, PhD, FACP, Director of the Thoracic and Phase I Program at the Virginia Cancer Specialists, the US Oncology Network, met with Oncology Data Advisor to discuss his presentation about adagrasib for KRAS G12–mutated non–small cell lung cancer with active central nervous system (CNS) metastases.  
Exploring Treatment Outcomes for Lobular Breast Cancer With Jason Mouabbi, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Lobular Breast Cancer Histology and Research: Jason Mouabbi, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Jason Mouabbi of MD Anderson Cancer Center presented a poster focused on survival outcomes of patients with invasive lobular carcinoma treated with endocrine therapy plus a CDK4/6 inhibitor, mammalian target of rapamycin (mTOR) inhibitor, or a PI3K inhibitor, in comparison to those with metastatic hormone receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative invasive ductal carcinoma. Afterwards, he sat down with Oncology Data Advisor to explain the implication of the study's results and the need for additional research in the field of lobular breast cancer to improve patient outcomes.  This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.  
Increasing Medical Student Confidence When Treating LGBTQIA+ Patients With Cherry Au, MD
Lyn Brook
Expert Analysis
Following the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Cherry Au, MD, of Rush University Medical Center, spoke with Oncology Data Advisor to discuss her abstract, Medical Student Clinical Cultural Awareness in Cancer Care of Sexual and Gender Minorities.  
Sharing the Breast Cancer Journey From Diagnosis to Survivorship With Megan-Claire Chase
Keira Smith
Expert Analysis
Oncology Data Advisor™ · A Patient's Perspective on Breast Cancer and Advocacy: Megan - Claire Chase At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Megan-Claire Chase, breast cancer survivor and Breast Cancer Program Director at SHARE Cancer Support, sat down with Oncology Data Advisor to talk about her diagnosis, treatment, and survivorship journey, as well as her advocacy work to empower people living with cancer. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Understanding the Research on Novel Treatments and Nutritional Interventions for Multiple Myeloma With Urvi Shah, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · The Best of Multiple Myeloma Research at ASCO: Urvi Shah, MD During the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Urvi Shah from Memorial Sloan Kettering Cancer Center sat down with Oncology Data Advisor to share her perspectives on the exciting research that was presented in the poster discussion session she chaired on novel therapies for multiple myeloma. In addition, Dr. Shah explains more about her work to impact patients' quality of life and outcomes through nutritional interventions. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Discovering the Field of Ocular Oncology with Dan Gombos, MD, FACS
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Ocular Oncology and the Personalized Approach: Dan Gombos, MD At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dan Gombos, MD, FACS, of MD Anderson Cancer Center, sat down with Oncology Data Advisor to discuss the field of ocular oncology, the management of tumors that start in or spread to the eye, and the management of toxicity to the eye caused by the treatment of cancer. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Managing Cancer Care at Home With Kathi Mooney, PhD, RN, FAAN
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Remote Symptom Monitoring and Management: Kathi Mooney, PhD, RN At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Kathi Mooney, PhD, RN, FAAN, Professor in the College of Nursing at the University of Utah, sat down with Oncology Data Advisor to discuss her presentation and abstract about remote symptom management and the Huntsman at Home Rural Experience.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Creating an Inclusive Environment in Your Oncology Practice With Mark Fleming, MD
Lyn Brook
Expert Analysis
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Dr. Mark T. Fleming and colleagues, from the Virginia Oncology Associates, presented their poster about their initiative to foster a culture of inclusion in an independent community oncology and hematology practice that specializes in the diagnosis and treatment of cancer and blood disorders.  
Revolutionizing Tissue-Based Research Through Pathology and Artificial Intelligence With Jon Wetzel and Leif Honda
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Biospecimens and AI in Oncology Research: Leif Honda And Jon Wetzel At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Jon Wetzel, Chief Operating Officer (COO), and Leif Honda, Chief Innovation Officer (CIO) of TriMetis, a life sciences technology company, sat down with Oncology Data Advisor to talk about using artificial intelligence (AI) and computer-assisted pathology to revolutionize tissue-based research.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Perspectives on the Exciting Research at ASCO From Navdeep Dehar, MD, MBT, CCRP
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Perspectives on the Most Exciting Research at ASCO: Navdeep Dehar, MD At the American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Navdeep Dehar, a Medical Oncology Fellow at Queen's University in Ontario, sat down with Oncology Data Advisor to share the excitement of her first ASCO experience and the valuable research being presented there.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Targeting HRAS Mutations in Breast Cancer With Sam Kareff, MD, MPH
Keira Smith
Expert Analysis
Oncology Data Advisor™ · HRAS Mutations in Breast Cancer: Sam Kareff, MD, MPH Large population next-generation sequencing of tumors for mutations in certain key oncogenes is an important avenue of research for discovering genes that can predict survival or even support the use of targeted therapies for certain patients. At the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Sam Kareff, MD, MPH, presented a poster about his research about how mutations in the oncogene HRAS affect prognosis and response to therapy in breast cancer. He determined that certain types of HRAS mutation are associated with poor survival and that patients with these mutations may benefit from targeted therapies. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Understanding Bias Experienced by Caregivers Regarding Cancer-Related Decisions With Nick Dionne-Odom, PhD, RN
Lyn Brook
Expert Analysis
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Nick Dionne-Odom, PhD, RN, Assistant Professor in the University of Alabama at Birmingham School of Nursing and School of Geriatric and Palliative Care, presented a poster about his clinical trial exploring cancer-related decisions and the health care team bias experienced by caregivers regarding these decisions. Afterwards, he spoke with Oncology Data Advisor to shed further light on the trial's results.  

Copyright © 2022 Oncology Data Advisor. All rights reserved.